CarioH. Childhood polycythemias/erythrocytoses: classification, diagnosis, clinical presentation, and treatment. Ann Hematol. 2005;84:137-145.
2.
TefferiAVardimanJW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22:14-22.
3.
TefferiAThieleJOraziA. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092-1097.
4.
TeofiliLGionaFMartiniM. The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood. 2007;110:3384-3386.
5.
McNallyRJRowlandDRomanECartwrightRA. Age and sex distributions of hematological malignancies in the U.K.Hematol Oncol. 1997;15:173-189.
6.
OsgoodEE. Polycythemia vera: Age relationships and survival. Blood. 1965;26:243-256.
7.
PaukkuKSilvennoinenO. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev. 2004;15:435-455.
8.
KralovicsRPassamontiFBuserAS. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779-1790.
9.
CarioHMcMullinMFPahlHL. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol. 2009;88:713-719.
10.
TeofiliLGionaFMartiniM. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol. 2007;25:1048-1053.
11.
BayraktarYHarmanciOBüyükasikY. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci. 2008;53:2778-2783.
12.
BottoLDYangQ. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol. 2000;151:862-877.
13.
KenetGLütkhoffLKAlbisettiM. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-analysis of observational studies. Circulation. 2010;121:1838-1847.
14.
KwapiszJZekanowskaEJasiniewskaJ. Decreased serum prohepcidin concentration in patients with polycythemia vera. J Zhejiang Univ Sci B. 2009;10:791-795.
CorriganJJ. Hematologic aspects of pediatric cardiology. In: AllenHDDriscollDJShaddyREFeltesTF, eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 7th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1514-1524.
17.
PardananiATefferiA. Targeting myeloproliferative neoplasms with JAK inhibitors. Curr Opin Hematol. 2011;18:105-110.